CT/MRI LI-RADS v2017 – review of the guidelines
More details
Hide details
Submission date: 2018-02-26
Final revision date: 2018-05-13
Acceptance date: 2018-05-14
Publication date: 2018-07-16
Pol J Radiol, 2018; 83: 355-365
The Liver Imaging-Reporting and Data System (LI-RADS or LR) is a classification system for reading and reporting imaging studies in patients with high risk for hepatocellular carcinoma (HCC). One of its main goals is to improve communication between specialties, especially radiologists, hepatologists, surgeons, and pathologists. LI-RADS defines imaging features of the lesions and stratifies the risk of HCC into categories. It is the most comprehensive and highly specific system; however, its seeming complexity prevents many radiologists from using it in everyday practice. This article is a detailed review of the latest version of LI-RADS (v. 2017), which should be helpful for radiologists who are not very familiar with the system and its latest update.
LI-RADS CT/MRI v. 2017 [Internet]. Available from:
Cruite I, Tang A, Sirlin CB. Imaging-based diagnostic systems for hepatocellular carcinoma. Am J Roentgenol 2013; 201: 41-55.
Liu W, Qin J, Guo R, et al. Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS. Acta Radiol 2018; 59: 140-146.
Abd Alkhalik Basha M, Abd El Aziz El Sammak D, El Sammak AA. Diagnostic efficacy of the Liver Imaging-Reporting and Data System (LI-RADS) with CT imaging in categorising small nodules (10-20 mm) detected in the cirrhotic liver at screening ultrasound. Clin Radiol 2017; 72: 901.e1-901.e11.
Kim YY, An C, Kim S, Kim M. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI. Eur Radiol 2018; 28: 2038-2046.
Murakami T, Kim T, Takamura M, et al. Hypervascular hepatocellular carcinoma: detection with double arterial phase multi-detector row helical CT. Radiology 2001; 218: 763-767.
Ichikawa T, Kitamura T, Nakajima H, et al. Hypervascular hepatocellular carcinoma: can double arterial phase imaging with multidetector CT improve tumor depiction in the cirrhotic liver? AJR Am J Roentgenol 2002; 179: 751-758.
Chernyak V, Tang A, Flusberg M, et al. LI-RADS ancillary features on CT and MRI. Abdom Radiol (NY) 2018; 43: 82-100.
Bruix J, Sherman M. Management of hepatocellular carcinoma: An update. Hepatology 2011; 53: 1020-1022.
Dufour JF, Greten TF, Raymond E, et al. Clinical Practice Guidelines EASL – EORTC Clinical Practice Guidelines : Management of hepatocellular carcinoma European Organisation for Research and Treatment of Cancer. J Hepatol 2012; 56: 908-943.
Kudo M. Clinical Practice Guidelines for Hepatocellular Carcinoma Differ between Japan , United States , and Europe. Liver Cancer 2015; 4: 85-95.
Wald C, Russo MW, Heimbach JK, et al. New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 2013; 266: 376-382.
Yoon SH, Lee JM, So YH, et al. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: Tumor size and cellular differentiation. Am J Roentgenol 2009; 193: 482-489.
Khalili K, Kyoung Kim T, Jang HJ, et al. Indeterminate 1-2-cm nodules found on hepatocellular carcinoma surveillance: Biopsy for all, some, or none? Hepatology 2011; 54: 2048-2054.
Journals System - logo
Scroll to top